Researchers have found that antibodies against the human papillomavirus (HPV) may help identify individuals who are at greatly increased risk of HPV-related cancer of the oropharynx, which is a portion of the throat that contains the tonsils.
NCI funded a clinical trial that will have an impact on the treatment of late-stage cervical cancer, and also supported a screening trial in India using a network of community outreach workers offering low tech-screening by direct visualization of the cervix coated with dilute acetic acid (vinegar), a process known as VIA. Image depicts cervical cancer microvessel density which increases lethality of the cancer.
More often than not, cancer immunotherapies that work in adults are used in modified ways in children. Seldom are new therapies developed just for children, primarily because of the small number of pediatric patients relative to the adult cancer patient population. Depicted are members of NCI’s Pediatric Oncology Branch. From left: Drs. Crystal Mackall, Daniel Lee, and Alan Wayne
A year ago, Colleen Williams was into the natural look. She seldom bothered to put on makeup and she let her long, wavy, brown hair flow free. Cancer treatment changed that. These days, when she feels well enough to go to work, Williams wears her “cute hat” to cover her newly-balding head and takes a little extra time in the morning to pencil in her thinning brows and apply concealer to make her skin look a little less gray.
Sometimes rising or falling trends in cancer rates can mask more complicated scientific aspects of the disease. Consider a relatively rare form of leukemia known as AML that predominantly affects middle-age and elderly adults. Based on data from NCI and others recently released in the Annual Report to the Nation, an estimated 14,000 people will develop AML in the United States in 2013, and an estimated 10,000 people will die from it.
The Annual Report to the Nation on the Status of Cancer, 1975–2009, shows that overall cancer death rates continued to decline in the U.S. among both men and women, among all major racial and ethnic groups, and for all of the most common cancer sites.
- Reforms speed initiation of NCI-sponsored clinical trialsJune 17, 2013
- Scientists find promising predictor of HPV-related oropharynx cancerJune 17, 2013
- Cervical Cancer: paradigms at home and abroadJune 2, 2013
- NCI-supported research at ASCO June 2, 2013
Obtaining an NCI designation for a cancer center is usually a years-long process of building — facilities, faculty, and most importantly, a research portfolio — culminated by a rigorous review process. Selection provides recognition of research excellence
- Diabetes drug points way to overcoming melanoma drug resistanceJune 17, 2013
- Using genetic variations to predict breast cancer riskJune 14, 2013
- Protein protects against breast cancer recurrence in animal modelJune 14, 2013
- Developmental protein plays role in spread of cancerJune 14, 2013